GlassScriptPhysician profile
Eric S Roccario
NPI 1538167697
$11,553.69
in general payments reported to CMS, 2019-2025
20 companies · $3,110 in 2025
The $3,110 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,658 · 2020: $490 · 2021: $3,724 · 2022: $661 · 2023: $698 · 2024: $1,212 · 2025: $3,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,021 · Travel and Lodging: $1,999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,020.57 |
| Travel and Lodging | $1,999.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $8,975.45 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $635.90 | 2021-2025 | Impella |
| Boston Scientific Corporation | $330.38 | 2019-2024 | Ekosonic |
| Abbott Laboratories | $309.79 | 2019-2025 | Dragonfly Opstar |
| Artivion, INC. | $237.25 | 2022 | |
| Medtronic, INC. | $198.01 | 2022-2024 | Corevalve Evolut R |
| Angiodynamics, INC. | $197.83 | 2024 | Angiovac |
| Novartis Pharmaceuticals Corporation | $172.63 | 2019-2025 | |
| Inari Medical, INC. | $140.72 | 2019 | |
| Pfizer INC. | $111.11 | 2023-2025 | |
| Cvrx, INC. | $56.45 | 2023 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.52 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $29.29 | 2025 | Camzyos |
| Agepha Pharma Fz LLC | $25.35 | 2025 | Lodoco |
| Cardiva Medical, INC. | $21.54 | 2025 | Savvywire |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $17.99 | 2025 | |
| Novo Nordisk INC | $15.59 | 2025 | Wegovy |
| Acist Medical Systems, INC. | $14.19 | 2019 | |
| Medtronic Vascular, INC. | $11.54 | 2019 | |
| Cardiovascular Systems INC. | $9.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Roccario listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.